Literature DB >> 30950055

The R249Q hypertrophic cardiomyopathy myosin mutation decreases contractility in Drosophila by impeding force production.

Kaylyn M Bell1, William A Kronert2, Alice Huang1, Sanford I Bernstein2, Douglas M Swank1.   

Abstract

KEY POINTS: Hypertrophic cardiomyopathy (HCM) is a genetic disease that causes thickening of the heart's ventricular walls and is a leading cause of sudden cardiac death. HCM is caused by missense mutations in muscle proteins including myosin, but how these mutations alter muscle mechanical performance in largely unknown. We investigated the disease mechanism for HCM myosin mutation R249Q by expressing it in the indirect flight muscle of Drosophila melanogaster and measuring alterations to muscle and flight performance. Muscle mechanical analysis revealed R249Q decreased muscle power production due to slower muscle kinetics and decreased force production; force production was reduced because fewer mutant myosin cross-bridges were bound simultaneously to actin. This work does not support the commonly proposed hypothesis that myosin HCM mutations increase muscle contractility, or causes a gain in function; instead, it suggests that for some myosin HCM mutations, hypertrophy is a compensation for decreased contractility. ABSTRACT: Hypertrophic cardiomyopathy (HCM) is an inherited disease that causes thickening of the heart's ventricular walls. A generally accepted hypothesis for this phenotype is that myosin heavy chain HCM mutations increase muscle contractility. To test this hypothesis, we expressed an HCM myosin mutation, R249Q, in Drosophila indirect flight muscle (IFM) and assessed myofibril structure, skinned fibre mechanical properties, and flight ability. Mechanics experiments were performed on fibres dissected from 2-h-old adult flies, prior to degradation of IFM myofilament structure, which started at 2 days old and increased with age. Homozygous and heterozygous R249Q fibres showed decreased maximum power generation by 67% and 44%, respectively. Decreases in force and work and slower overall muscle kinetics caused homozygous fibres to produce less power. While heterozygous fibres showed no overall slowing of muscle kinetics, active force and work production dropped by 68% and 47%, respectively, which hindered power production. The muscle apparent rate constant 2πb decreased 33% for homozygous but increased for heterozygous fibres. The apparent rate constant 2πc was greater for homozygous fibres. This indicates that R249Q myosin is slowing attachment while speeding up detachment from actin, resulting in less time bound. Decreased IFM power output caused 43% and 33% decreases in Drosophila flight ability and 19% and 6% drops in wing beat frequency for homozygous and heterozygous flies, respectively. Overall, our results do not support the increased contractility hypothesis. Instead, our results suggest the ventricular hypertrophy for human R249Q mutation is a compensatory response to decreases in heart muscle power output.
© 2019 The Authors. The Journal of Physiology © 2019 The Physiological Society.

Entities:  

Keywords:  Hypertrophic cardiomyopathy; Insect; Locomotion; Muscle physiology; Myosin

Year:  2019        PMID: 30950055      PMCID: PMC6487941          DOI: 10.1113/JP277333

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  65 in total

1.  Mutation of the myosin converter domain alters cross-bridge elasticity.

Authors:  Jan Köhler; Gerhard Winkler; Imke Schulte; Tim Scholz; William McKenna; Bernhard Brenner; Theresia Kraft
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-19       Impact factor: 11.205

2.  A structural state of the myosin V motor without bound nucleotide.

Authors:  Pierre-Damien Coureux; Amber L Wells; Julie Ménétrey; Christopher M Yengo; Carl A Morris; H Lee Sweeney; Anne Houdusse
Journal:  Nature       Date:  2003-09-25       Impact factor: 49.962

Review 3.  Determining structure/function relationships for sarcomeric myosin heavy chain by genetic and transgenic manipulation of Drosophila.

Authors:  D M Swank; L Wells; W A Kronert; G E Morrill; S I Bernstein
Journal:  Microsc Res Tech       Date:  2000-09-15       Impact factor: 2.769

4.  Beta-myosin heavy chain gene mutations and hypertrophic cardiomyopathy in Austrian children.

Authors:  S Greber-Platzer; M Marx; C Fleischmann; C Suppan; M Dobner; M Wimmer
Journal:  J Mol Cell Cardiol       Date:  2001-01       Impact factor: 5.000

5.  R403Q and L908V mutant beta-cardiac myosin from patients with familial hypertrophic cardiomyopathy exhibit enhanced mechanical performance at the single molecule level.

Authors:  K A Palmiter; M J Tyska; J R Haeberle; N R Alpert; L Fananapazir; D M Warshaw
Journal:  J Muscle Res Cell Motil       Date:  2000       Impact factor: 2.698

6.  Functional consequences of mutations in the smooth muscle myosin heavy chain at sites implicated in familial hypertrophic cardiomyopathy.

Authors:  H Yamashita; M J Tyska; D M Warshaw; S Lowey; K M Trybus
Journal:  J Biol Chem       Date:  2000-09-08       Impact factor: 5.157

7.  Single-molecule mechanics of R403Q cardiac myosin isolated from the mouse model of familial hypertrophic cardiomyopathy.

Authors:  M J Tyska; E Hayes; M Giewat; C E Seidman; J G Seidman; D M Warshaw
Journal:  Circ Res       Date:  2000-04-14       Impact factor: 17.367

8.  Altered crossbridge kinetics in the alphaMHC403/+ mouse model of familial hypertrophic cardiomyopathy.

Authors:  E Blanchard; C Seidman; J G Seidman; M LeWinter; D Maughan
Journal:  Circ Res       Date:  1999-03-05       Impact factor: 17.367

9.  Differential cross-bridge kinetics of FHC myosin mutations R403Q and R453C in heterozygous mouse myocardium.

Authors:  Bradley M Palmer; David E Fishbaugher; Joachim P Schmitt; Yuan Wang; Norman R Alpert; Christine E Seidman; J G Seidman; Peter VanBuren; David W Maughan
Journal:  Am J Physiol Heart Circ Physiol       Date:  2004-03-04       Impact factor: 4.733

10.  Visualization of head-head interactions in the inhibited state of smooth muscle myosin.

Authors:  T Wendt; D Taylor; T Messier; K M Trybus; K A Taylor
Journal:  J Cell Biol       Date:  1999-12-27       Impact factor: 10.539

View more
  6 in total

1.  Shortening deactivation: quantifying a critical component of cyclical muscle contraction.

Authors:  Amy K Loya; Sarah K Van Houten; Bernadette M Glasheen; Douglas M Swank
Journal:  Am J Physiol Cell Physiol       Date:  2021-12-29       Impact factor: 4.249

2.  Myosin motor domains carrying mutations implicated in early or late onset hypertrophic cardiomyopathy have similar properties.

Authors:  Carlos D Vera; Chloe A Johnson; Jonathan Walklate; Arjun Adhikari; Marina Svicevic; Srboljub M Mijailovich; Ariana C Combs; Stephen J Langer; Kathleen M Ruppel; James A Spudich; Michael A Geeves; Leslie A Leinwand
Journal:  J Biol Chem       Date:  2019-10-03       Impact factor: 5.157

3.  Prolonged myosin binding increases muscle stiffness in Drosophila models of Freeman-Sheldon syndrome.

Authors:  Kaylyn M Bell; Alice Huang; William A Kronert; Sanford I Bernstein; Douglas M Swank
Journal:  Biophys J       Date:  2021-01-30       Impact factor: 4.033

Review 4.  Drosophila Heart as a Model for Cardiac Development and Diseases.

Authors:  Anissa Souidi; Krzysztof Jagla
Journal:  Cells       Date:  2021-11-08       Impact factor: 6.600

5.  The R369 Myosin Residue within Loop 4 Is Critical for Actin Binding and Muscle Function in Drosophila.

Authors:  Adriana S Trujillo; Karen H Hsu; Meera C Viswanathan; Anthony Cammarato; Sanford I Bernstein
Journal:  Int J Mol Sci       Date:  2022-02-25       Impact factor: 5.923

6.  Myosin Transducer Inter-Strand Communication Is Critical for Normal ATPase Activity and Myofibril Structure.

Authors:  William A Kronert; Karen H Hsu; Aditi Madan; Floyd Sarsoza; Anthony Cammarato; Sanford I Bernstein
Journal:  Biology (Basel)       Date:  2022-07-29
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.